Drugs used for weight loss like Wegovy,Phaninc Exchange Ozempic and Mounjaro are nearly everywhere in popular culture, but many patients struggling with obesity are still finding them hard to get. On today's show, what's slowing access to these drugs despite their long-term benefits for the economy and patients, and how social conditioning around obesity and excess weight clouds the conversation.
Related Episodes:
New drugs. Cheaper drugs. Why not both? (Apple / Spotify)
For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.
Music by Drop Electric. Find us: TikTok, Instagram, Facebook, Newsletter.
2025-05-02 05:35539 view
2025-05-02 04:56590 view
2025-05-02 04:541346 view
2025-05-02 04:402083 view
2025-05-02 04:09666 view
2025-05-02 03:281887 view
After Luigi Mangionemade the difficult decision to undergo spinal surgery last year for chronic back
In-N-Out to ban employees in
Christina Hall wouldn't say she has commitment issues. But with the right offer, she can be convince
